Navigation Links
CEL-SCI Corporation Releases Letter to Shareholders
Date:2/20/2009

help us with this process we have hired BroadOak Capital Partners, an investment bank with a comprehensive focus on the life sciences industry.

  1. We are working on licensing agreements for Multikine to pay for the Phase III trial because raising the amount of money required for the trial at the current prices would be harmful to our shareholders;
  2. We are working on a joint venturing agreement for the same reason;
  3. We are in discussions to use our manufacturing facility as a contract manufacturing facility while it is not being used to produce Multikine;
  4. We have also signed a $5 million line of credit to be used if necessary. This line is not intended to be our primary funding source but does serve as additional insurance to shareholders;
  5. We have a few other, some of them "out of the box" ideas, ongoing.

We hope to bring at least one of these projects to a conclusion very soon.

We cannot change the economic climate or the damage that the financial crisis has caused to the countless stocks, us included, but we are trying to structure our future steps to create the greatest value for CEL-SCI shareholders. We are being very careful and deliberate, working closely with our various partners, suppliers, etc as we adapt to the current environment.

We believe that as a cancer company ready to start a pivotal Phase III clinical trial with a completely novel and non-toxic cancer therapy, we are well positioned for licensing, joint venture and other business arrangements. In normal times these deals might already have been completed a while ago and we would have already started the Phase III trial. In the last few months almost all investments have been hit hard and everything just seems to take longer. Our valuation is currently very low. However, please do not confuse our share price with th
'/>"/>

SOURCE CEL-SCI Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. CEL-SCI Announces Expansion of Exclusive Licensing Agreement for Cancer Drug Multikine
2. CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect
3. CEL-SCI Expects to Take Delivery of New Manufacturing Facility on October 8, 2008
4. Data Suggest CEL-SCIs CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis
5. CEL-SCI Corporation Reports First Quarter Financial Results
6. CEL-SCI Corporation Announces 2007 Financial Results
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
8. CEL-SCI to Present at Rodman & Renshaw 9th Annual Healthcare Conference
9. CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase
10. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
11. CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)...  This year alone, The Leukemia & Lymphoma Society ... one goal in mind: Discovering lifesaving therapies for blood ... a flagship LLS fundraising campaign and the world,s first ... landmark 25 th anniversary. To date, TNT has ... to discover and deliver breakthrough cancer treatments that are ...
(Date:6/19/2013)... Pharma IQ is pleased to announce the release ... results from an industry survey conducted earlier this year. ... would be an area of active investment in the next ... more clinical trials in the BRIC region. The infographic, created ... Summit explores the latest trends, challenges and opportunities ...
(Date:6/18/2013)... June 18, 2013  Intercept Pharmaceuticals, Inc.  (NASDAQ: ... on the development and commercialization of novel bile acid ... pricing of an underwritten public offering of 1,730,000 shares ... of $33.01 per share.  In addition, Intercept has granted ... an additional 259,500 shares of common stock. ...
Breaking Medicine Technology:Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients 2Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients 3Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients 4Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients 5Pharma IQ Presents the Latest Trends in Clinical Trial Supply 2Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2
... 4, 2011 Eli Lilly and Company (NYSE: ... studies of molecules that target genetic mutations and disable ... studies evaluated two unique molecules – a JAK2 inhibitor ... the American Association for Cancer Research (AACR) 102nd Annual ...
... announcing that it entered into an agreement with Oman Pharmaceutical ... Neomycin Sulfate Tablets. Under the terms of the agreement, the ... distributed by Breckenridge on an exclusive basis in the United ... and Drug Administration (FDA), and the companies began shipping the ...
Cached Medicine Technology:Two Novel Lilly Molecules Target Genetic Mutations That Can Lead to Cancer 2Two Novel Lilly Molecules Target Genetic Mutations That Can Lead to Cancer 3Two Novel Lilly Molecules Target Genetic Mutations That Can Lead to Cancer 4
(Date:6/19/2013)... DiscountFurnaceFilter.com, the number one solution for homeowner’s ... Compressor Saver kit at an exceptional price. The 5-2-1 Compressor ... air conditioning unit during start up, saving wear and tear ... unit burn out. , The 5-2-1 Compressor Saver ... uses less power to start and drastically reduces the rush ...
(Date:6/19/2013)... 19, 2013 Kansas City will host its first ... Street Day . A section of Main Street in the midtown ... afternoon of the event. The Main Street Corridor Development ... will help Kansas City join the ranks of dozens of cities ... tool to foster community vibrancy and active lifestyles. , “Ciclovia is ...
(Date:6/19/2013)... June 19, 2013 In 2011, the ... EUR 710 million. Generic drugs form the largest sector, ... value. The pharmaceutical industry is a significant contributor to ... the country’s GDP. Approximately 50% of the total domestic ... pharmaceutical industry. Hemofarm, Galenika and Zdravlje Actavis are key ...
(Date:6/19/2013)... Elsevier, a world-leading provider of scientific, technical ... the publication of the National Osteoporosis Guideline Group ... osteoporosis in postmenopausal women and older men in ... 2009 in Maturitas , the original guidelines ... timely with an additional focus on the management ...
(Date:6/19/2013)... Next Thursday, June 27, 2013, ... organization, and Muzzy Lane Software , a ... the Games for Health community to their interactive ... toward students in grades 4-7 and designed to ... positive choices. The game is part of a ...
Breaking Medicine News(10 mins):Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 2Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 3Health News:Serbian Pharmaceutical Market Scrutinized by CUBE in Topical Report Now Available at MarketPublishers.com 2Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 2Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 3Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 4Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 5
... Fla. and COLUMBUS, Ohio, May 20 Axium ... specialty pharmacy providers, and Definitive Homecare Solutions, the ... of CPR+ as its specialty pharmacy management software ... continued growth, we needed a software platform to ...
... The Technical Board of,Appeal of the European Patent Office ... two competitors against an earlier decision to maintain the,European ... http://www.newscom.com/cgi-bin/prnh/20090520/347917-a ) , ... Introduced in 1999, the VisionBlue product is protected ...
... managed by a specialty pharmacy program were more compliant ... hospitalized for their disease than those who were not ... study completed by HealthCore, Inc. , HealthCore researcher Jingbo ... of Pharmacoeconomic and Outcomes Research 14th Annual International Meeting ...
... RECORDING OF DAVID COOK,S ,IDOL, PERFORMANCE WILL BE SOLD ... Sale of Live Version of ,Permanent, Will Be Donated ... Exactly one year after winning the seventh season ... popular television series in America on Wednesday night to ...
... To commemorate the 80th anniversary of The Children,s ... in Midtown Detroit, a Power of Possibilities Breakfast is ... Book Cadillac.(Logo: http://www.newscom.com/cgi-bin/prnh/20090423/CCWCLOGO ) ... on the ideologies of founder Senator James Couzens. ...
... Ill., May 20 Viant, Inc., a leader in ... they have signed an agreement with Tempe, AZ-based HMA, ... the state of Arizona. Viant customers utilizing the Beech ... access to HMA, Inc.,s Arizona provider networks, which include, ...
Cached Medicine News:Health News:Axium Healthcare Picks CPR+ as Its Specialty Pharmacy Management Software 2Health News:Axium Healthcare Picks CPR+ as Its Specialty Pharmacy Management Software 3Health News:Appeal Proceedings on European VisionBlue Patent Stayed; Patent Remains in Force 2Health News:Appeal Proceedings on European VisionBlue Patent Stayed; Patent Remains in Force 3Health News:MS patients more compliant with medications when managed by specialty pharmacy 2Health News:David Cook to Perform 'Permanent' on the American Idol Season Finale Tonight 2Health News:80th Anniversary Power of Possibilities Breakfast Honors the Children's Center of Wayne County 2Health News:Viant Expands Relationship With HMA for Improved Healthcare Access in AZ 2
The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
Hook design lifts and separates tissue for efficient dissection. Cautery action facilitates immediate control of bleeders....
The Bair Hugger Model 505 provides safe, quiet and effective warming to patients around the world....
... has it's temperature set by means ... pressing a button. A green LED ... a flashing amber LED indicates the ... A red LED and an audible ...
Medicine Products: